66 related articles for article (PubMed ID: 6733256)
21. Identification of a hydroxylamine glucuronide metabolite of an oral hypoglycemic agent.
Miller RR; Doss GA; Stearns RA
Drug Metab Dispos; 2004 Feb; 32(2):178-85. PubMed ID: 14744939
[TBL] [Abstract][Full Text] [Related]
22. Disposition of remoxipride in different species. Species differences in metabolism.
Widman M; Nilsson LB; Bryske B; Lundström J
Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555
[TBL] [Abstract][Full Text] [Related]
23. Discrimination of cell nuclei in early S-phase, mid-to-late S-phase, and G(2)/M-phase by sequential administration of 5-bromo-2'-deoxyuridine and 5-chloro-2'-deoxyuridine.
Yamada K; Semba R; Ding X; Ma N; Nagahama M
J Histochem Cytochem; 2005 Nov; 53(11):1365-70. PubMed ID: 15956030
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, biotransformation, pharmacokinetics, and antiviral properties of 5-ethyl-5-halo-6-methoxy-5,6-dihydro-2'-deoxyuridine diastereomers.
Cheraghali AM; Kumar R; Wang L; Knaus EE; Wiebe LI
Biochem Pharmacol; 1994 Apr; 47(9):1615-25. PubMed ID: 8185676
[TBL] [Abstract][Full Text] [Related]
25. Column-switching high-performance liquid chromatography combined with ionspray tandem mass spectrometry for the simultaneous determination of the platelet inhibitor Ro 44-3888 and its pro-drug and precursor metabolite in plasma.
Zell M; Husser C; Hopfgartner G
J Mass Spectrom; 1997 Jan; 32(1):23-32. PubMed ID: 9008866
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biodistribution of [4-14C]-5-bromo-6-methoxy-5,6-dihydro-prodrug derivatives of 5-ethyl-2'-deoxyuridine.
Cheraghali AM; Morin KW; Kumar R; Knaus EE; Wiebe LI
Drug Des Discov; 1994 Jul; 12(1):53-61. PubMed ID: 7578807
[TBL] [Abstract][Full Text] [Related]
27. Comparative assessment of distribution of blackcurrant anthocyanins in rabbit and rat ocular tissues.
Matsumoto H; Nakamura Y; Iida H; Ito K; Ohguro H
Exp Eye Res; 2006 Aug; 83(2):348-56. PubMed ID: 16635490
[TBL] [Abstract][Full Text] [Related]
28. Disposition of the antipsychotic agent CI-1007 in rats, monkeys, dogs, and human cytochrome P450 2D6 extensive metabolizers. Species comparison and allometric scaling.
Feng MR; Loo J; Wright J
Drug Metab Dispos; 1998 Oct; 26(10):982-8. PubMed ID: 9763403
[TBL] [Abstract][Full Text] [Related]
29. Investigation of the metabolic fate of 2-, 3- and 4-bromobenzoic acids in bile-duct-cannulated rats by inductively coupled plasma mass spectrometry and high-performance liquid chromatography/inductively coupled plasma mass spectrometry/electrospray mass spectrometry.
Jensen BP; Smith CJ; Bailey CJ; Rodgers C; Wilson ID; Nicholson JK
Rapid Commun Mass Spectrom; 2005; 19(4):519-24. PubMed ID: 15666316
[TBL] [Abstract][Full Text] [Related]
30. Development of a liquid chromatographic/tandem mass spectrometric assay for a new endothelin receptor antagonist, and its application to dog plasma samples generated after simultaneous i.v. and p.o. administration of the unlabeled and deuterium-labeled forms of this antagonist.
Lausecker B; Fischer G
J Mass Spectrom; 2003 Jun; 38(6):649-58. PubMed ID: 12827634
[TBL] [Abstract][Full Text] [Related]
31. Identification of talinolol metabolites in urine of man, dog, rat and mouse after oral administration by high-performance liquid chromatography-thermospray tandem mass spectrometry.
Schupke H; Hempel R; Eckardt R; Kronbach T
J Mass Spectrom; 1996 Dec; 31(12):1371-81. PubMed ID: 8990520
[TBL] [Abstract][Full Text] [Related]
32. In Vitro and In Vivo pharmacokinetic studies of bulaquine (analogue of primaquine), a novel antirelapse antimalarial, in rat, rabbit and monkey--highlighting species similarities and differences.
Mehrotra N; Lal J; Puri SK; Madhusudanan KP; Gupta RC
Biopharm Drug Dispos; 2007 Jul; 28(5):209-27. PubMed ID: 17410524
[TBL] [Abstract][Full Text] [Related]
33. Directly coupled liquid chromatography with inductively coupled plasma mass spectrometry and orthogonal acceleration time-of-flight mass spectrometry for the identification of drug metabolites in urine: application to diclofenac using chlorine and sulfur detection.
Corcoran O; Nicholson JK; Lenz EM; Abou-Shakra F; Castro-Perez J; Sage AB; Wilson ID
Rapid Commun Mass Spectrom; 2000; 14(24):2377-84. PubMed ID: 11114054
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of (S)-HPMPA against thymidine kinase-deficient herpes simplex virus-keratitis.
Maudgal PC; De Clercq E; Huyghe P
Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):243-8. PubMed ID: 8591903
[TBL] [Abstract][Full Text] [Related]
35. Structure elucidation of three isomeric metabolites of SYN-2836, a novel antifungal agent, in dogs via liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry methodologies.
Bu HZ; Poglod M; Micetich RG; Khan JK
J Mass Spectrom; 1999 Nov; 34(11):1185-94. PubMed ID: 10548812
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological studies on 5-methoxymethyl-2'-deoxyuridine: a new antiviral agent.
Meldrum JB; Gupta VS; Taneja AK; Sisodia CS
J Pharmacol Exp Ther; 1981 Feb; 216(2):275-80. PubMed ID: 7463349
[TBL] [Abstract][Full Text] [Related]
37. Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans.
Weinz C; Schwarz T; Kubitza D; Mueck W; Lang D
Drug Metab Dispos; 2009 May; 37(5):1056-64. PubMed ID: 19196845
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of prulifloxacin. 3rd communication: metabolism in rats, dogs and monkeys.
Okuyama Y; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):293-8. PubMed ID: 9105548
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 3rd communication: plasma concentrations of the unchanged drug and its deethylated metabolite in rats, dogs and monkeys.
Nakamura A; Hirota T; Sugihara K; Morino A
Arzneimittelforschung; 1997 Feb; 47(2):169-74. PubMed ID: 9079236
[TBL] [Abstract][Full Text] [Related]
40. Biotransformation of the organic nitrate trans-N-(4-nitroxycyclohexyl)acetamide in dogs.
Zell C; Neidlein R; Strein K
Arzneimittelforschung; 1994 Sep; 44(9):1021-8. PubMed ID: 7986238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
